Abstract
Cancer Despite the explosion of research on chimeric antigen receptor (CAR) T cell therapy, most preclinical studies use transduced human T cells in immunodeficient mice. To determine how CAR activity is affected by T cell receptor (TCR) engagement, Yang et al. used a CAR targeting CD19 and
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have